Abate thomas m - direct investment history in Edwards lifesciences corp

Filed on 2013-05-16 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-012559.txt Sec File: edgar/data/1346974/0001225208-13-012559-index.htm

2013-05-14 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 61100.0000 shares at $0.0000 remaining shares owned 61100

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2013-06-14 exercise price 71.5700 has valueitem expiration due date 2020-05-13 underlying security shares 61100.0000 underlying security title Common Stock

f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.
f1 this option was granted on may 14, 2013 under the edwards lifesciences corporation long-term stock incentive compensation program and becomes exercisable commencing one month after the grant date in twenty-four equal monthly installments.


Filed on 2013-05-16 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-012559.txt Sec File: edgar/data/1346974/0001225208-13-012559-index.htm

2013-05-14 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 7200.0000 shares at $0.0000 remaining shares owned 7200

Performance Rights Edwards Lifesciences Corp Ew item expiration due date 2016-03-31 underlying security shares 7200.0000 underlying security title Common Stock

f3 reflects the target number of shares (the target award) covered by unvested restricted stock units granted on may 14, 2013. the number of shares issuable at vesting will depend upon achievement of the performance goals and will range from zero percent (0%) of the target award to one hundred seventy five percent (175%) of the target award.


Filed on 2013-05-15 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-012373.txt Sec File: edgar/data/1346974/0001225208-13-012373-index.htm

2013-05-13 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 1346 shares at $67.8700 remaining shares owned 43047

Common Stock Edwards Lifesciences Corp Ew Transaction code: F Payment of exercise price or tax liability by delivering or withholding securities

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-05-09 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-011895.txt Sec File: edgar/data/1346974/0001225208-13-011895-index.htm

2013-05-07 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 15000 shares at $21.9550 remaining shares owned 61689

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2012.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-05-09 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-011895.txt Sec File: edgar/data/1346974/0001225208-13-011895-index.htm

2013-05-07 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 15000 shares at $63.7500 remaining shares owned 44393

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2012.
f3 this transaction was executed in multiple trades at prices ranging from $63.22 to $64.01. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-05-09 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-011895.txt Sec File: edgar/data/1346974/0001225208-13-011895-index.htm

2013-05-07 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 15000.0000 shares at $0.0000 remaining shares owned 0

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2007-05-11 exercise price 21.9550 has valueitem expiration due date 2013-05-10 underlying security shares 15000.0000 underlying security title Common Stock

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2012.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-05-09 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-011895.txt Sec File: edgar/data/1346974/0001225208-13-011895-index.htm

2013-05-07 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 2296 shares at $63.6600 remaining shares owned 59393

Common Stock Edwards Lifesciences Corp Ew Transaction code: F Payment of exercise price or tax liability by delivering or withholding securities

f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-04-26 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-010469.txt Sec File: edgar/data/1346974/0001225208-13-010469-index.htm

2013-04-26 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 8800 shares at $64.4100 remaining shares owned 46688

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2012.
f4 this transaction was executed in multiple trades at prices ranging from $64.05 to $64.92. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-04-26 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-010469.txt Sec File: edgar/data/1346974/0001225208-13-010469-index.htm

2013-04-26 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 10000.0000 shares at $0.0000 remaining shares owned 15000

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2007-05-11 exercise price 21.9550 has valueitem expiration due date 2013-05-10 underlying security shares 10000.0000 underlying security title Common Stock

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2012.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-04-26 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-010469.txt Sec File: edgar/data/1346974/0001225208-13-010469-index.htm

2013-04-26 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 1200 shares at $65.3600 remaining shares owned 55488

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2012.
f3 this transaction was executed in multiple trades at prices ranging from $65.14 to $65.53. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-04-26 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-010469.txt Sec File: edgar/data/1346974/0001225208-13-010469-index.htm

2013-04-26 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 10000 shares at $21.9550 remaining shares owned 56688

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2012.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-04-09 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-009839.txt Sec File: edgar/data/1346974/0001225208-13-009839-index.htm

2013-04-06 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 173 shares at $81.4000 remaining shares owned 46688

Common Stock Edwards Lifesciences Corp Ew Transaction code: F Payment of exercise price or tax liability by delivering or withholding securities

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-04-09 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-009839.txt Sec File: edgar/data/1346974/0001225208-13-009839-index.htm

2013-04-05 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 147 shares at $82.4200 remaining shares owned 46861

Common Stock Edwards Lifesciences Corp Ew Transaction code: F Payment of exercise price or tax liability by delivering or withholding securities

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-04-04 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-009587.txt Sec File: edgar/data/1346974/0001225208-13-009587-index.htm

2013-04-03 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 347 shares at $0.0000 remaining shares owned 47008

Common Stock Edwards Lifesciences Corp Ew Transaction code: A Grant, award, or other acquisition

f1 reflects unvested restricted stock units granted on april 3, 2013.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person. this amount includes quarterly acquisition of shares under the edwards lifesciences corporation employee stock purchase plan as reflected on the most recent report of the plan administrator.


Filed on 2013-02-19 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-004558.txt Sec File: edgar/data/1346974/0001225208-13-004558-index.htm

2013-02-14 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 12000.0000 shares at $0.0000 remaining shares owned 25000

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2007-05-11 exercise price 21.9550 has valueitem expiration due date 2013-05-10 underlying security shares 12000.0000 underlying security title Common Stock

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2012.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-02-19 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-004558.txt Sec File: edgar/data/1346974/0001225208-13-004558-index.htm

2013-02-14 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 12000 shares at $86.3800 remaining shares owned 46474

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2012.
f3 this transaction was executed in multiple trades at prices ranging from $86.12 to $86.97. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-02-19 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-004558.txt Sec File: edgar/data/1346974/0001225208-13-004558-index.htm

2013-02-14 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 12000 shares at $21.9550 remaining shares owned 58474

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2012.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-02-11 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-003628.txt Sec File: edgar/data/1346974/0001225208-13-003628-index.htm

2013-02-07 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 10000.0000 shares at $0.0000 remaining shares owned 37000

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2007-05-11 exercise price 21.9550 has valueitem expiration due date 2013-05-10 underlying security shares 10000.0000 underlying security title Common Stock

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2012.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-02-11 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-003628.txt Sec File: edgar/data/1346974/0001225208-13-003628-index.htm

2013-02-07 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 1826.0000 shares at $0.0000 remaining shares owned 0

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2004-04-04 exercise price 13.8100 has valueitem expiration due date 2013-04-03 underlying security shares 1826.0000 underlying security title Common Stock

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2012.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-02-11 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-003628.txt Sec File: edgar/data/1346974/0001225208-13-003628-index.htm

2013-02-07 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 6120 shares at $85.1300 remaining shares owned 46474

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2012.
f5 this transaction was executed in multiple trades at prices ranging from $84.55 to $85.53. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-02-11 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-003628.txt Sec File: edgar/data/1346974/0001225208-13-003628-index.htm

2013-02-07 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 4506 shares at $86.0000 remaining shares owned 52594

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2012.
f4 this transaction was executed in multiple trades at prices ranging from $85.58 to $86.56. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-02-11 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-003628.txt Sec File: edgar/data/1346974/0001225208-13-003628-index.htm

2013-02-07 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 1200 shares at $86.6400 remaining shares owned 57100

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2012.
f3 this transaction was executed in multiple trades at prices ranging from $86.59 to $86.71. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-02-11 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-003628.txt Sec File: edgar/data/1346974/0001225208-13-003628-index.htm

2013-02-07 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 1826 shares at $13.8100 remaining shares owned 58300

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2012.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2013-02-11 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-13-003628.txt Sec File: edgar/data/1346974/0001225208-13-003628-index.htm

2013-02-07 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 10000 shares at $21.9550 remaining shares owned 56474

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 28, 2012.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-08-28 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-018674.txt Sec File: edgar/data/1346974/0001225208-12-018674-index.htm

2012-08-24 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 20000.0000 shares at $0.0000 remaining shares owned 0

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2007-02-15 exercise price 21.5000 has valueitem expiration due date 2013-02-15 underlying security shares 20000.0000 underlying security title Common Stock

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on may 31, 2012.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-08-28 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-018674.txt Sec File: edgar/data/1346974/0001225208-12-018674-index.htm

2012-08-24 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 11123 shares at $98.9500 remaining shares owned 46474

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on may 31, 2012.
f4 this transaction was executed in multiple trades at prices ranging from $98.32 to $99.30. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-08-28 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-018674.txt Sec File: edgar/data/1346974/0001225208-12-018674-index.htm

2012-08-24 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 8877 shares at $99.3700 remaining shares owned 57597

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on may 31, 2012.
f3 this transaction was executed in multiple trades at prices ranging from $99.32 to $99.48. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-08-28 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-018674.txt Sec File: edgar/data/1346974/0001225208-12-018674-index.htm

2012-08-24 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 20000 shares at $21.5000 remaining shares owned 66474

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on may 31, 2012.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-07-30 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-016839.txt Sec File: edgar/data/1346974/0001225208-12-016839-index.htm

2012-07-26 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 1900 shares at $104.0400 remaining shares owned 89574

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f2 this transaction was executed in multiple trades at prices ranging from $103.74 to $104.50. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person. this amount includes quarterly acquisition of shares under the edwards lifesciences corporation employee stock purchase plan as reflected on the most recent report of the plan administrator.


Filed on 2012-07-30 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-016839.txt Sec File: edgar/data/1346974/0001225208-12-016839-index.htm

2012-07-27 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 15000.0000 shares at $0.0000 remaining shares owned 20000

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2007-02-15 exercise price 21.5000 has valueitem expiration due date 2013-02-15 underlying security shares 15000.0000 underlying security title Common Stock

f6 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on march 31, 2012.
f9 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-07-30 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-016839.txt Sec File: edgar/data/1346974/0001225208-12-016839-index.htm

2012-07-26 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 45000.0000 shares at $0.0000 remaining shares owned 47000

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2007-05-11 exercise price 21.9550 has valueitem expiration due date 2013-05-10 underlying security shares 45000.0000 underlying security title Common Stock

f9 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-07-30 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-016839.txt Sec File: edgar/data/1346974/0001225208-12-016839-index.htm

2012-07-27 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 11200 shares at $105.2700 remaining shares owned 46474

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f6 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on march 31, 2012.
f8 this transaction was executed in multiple trades at prices ranging from $104.77 to $105.74. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person. this amount includes quarterly acquisition of shares under the edwards lifesciences corporation employee stock purchase plan as reflected on the most recent report of the plan administrator.


Filed on 2012-07-30 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-016839.txt Sec File: edgar/data/1346974/0001225208-12-016839-index.htm

2012-07-27 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 2800 shares at $103.9900 remaining shares owned 57674

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f6 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on march 31, 2012.
f7 this transaction was executed in multiple trades at prices ranging from $103.67 to $104.39. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person. this amount includes quarterly acquisition of shares under the edwards lifesciences corporation employee stock purchase plan as reflected on the most recent report of the plan administrator.


Filed on 2012-07-30 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-016839.txt Sec File: edgar/data/1346974/0001225208-12-016839-index.htm

2012-07-27 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 1000 shares at $103.1600 remaining shares owned 60474

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f6 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on march 31, 2012.
f4 this transaction was executed in multiple trades at prices ranging from $102.62 to $103.53. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person. this amount includes quarterly acquisition of shares under the edwards lifesciences corporation employee stock purchase plan as reflected on the most recent report of the plan administrator.


Filed on 2012-07-30 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-016839.txt Sec File: edgar/data/1346974/0001225208-12-016839-index.htm

2012-07-27 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 15000 shares at $21.5000 remaining shares owned 61474

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f6 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on march 31, 2012.
f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person. this amount includes quarterly acquisition of shares under the edwards lifesciences corporation employee stock purchase plan as reflected on the most recent report of the plan administrator.


Filed on 2012-07-30 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-016839.txt Sec File: edgar/data/1346974/0001225208-12-016839-index.htm

2012-07-26 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 23549 shares at $102.3300 remaining shares owned 46474

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f5 this transaction was executed in multiple trades at prices ranging from $101.62 to $102.62. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person. this amount includes quarterly acquisition of shares under the edwards lifesciences corporation employee stock purchase plan as reflected on the most recent report of the plan administrator.


Filed on 2012-07-30 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-016839.txt Sec File: edgar/data/1346974/0001225208-12-016839-index.htm

2012-07-26 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 11491 shares at $102.9800 remaining shares owned 70023

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f4 this transaction was executed in multiple trades at prices ranging from $102.62 to $103.53. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person. this amount includes quarterly acquisition of shares under the edwards lifesciences corporation employee stock purchase plan as reflected on the most recent report of the plan administrator.


Filed on 2012-07-30 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-016839.txt Sec File: edgar/data/1346974/0001225208-12-016839-index.htm

2012-07-26 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 8060 shares at $101.1400 remaining shares owned 81514

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f3 this transaction was executed in multiple trades at prices ranging from $100.61 to $101.59. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person. this amount includes quarterly acquisition of shares under the edwards lifesciences corporation employee stock purchase plan as reflected on the most recent report of the plan administrator.


Filed on 2012-07-30 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-016839.txt Sec File: edgar/data/1346974/0001225208-12-016839-index.htm

2012-07-26 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 45000 shares at $21.9550 remaining shares owned 91474

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person. this amount includes quarterly acquisition of shares under the edwards lifesciences corporation employee stock purchase plan as reflected on the most recent report of the plan administrator.


Filed on 2012-06-29 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-015065.txt Sec File: edgar/data/1346974/0001225208-12-015065-index.htm

2012-06-29 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 15000.0000 shares at $0.0000 remaining shares owned 35000

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2007-02-15 exercise price 21.5000 has valueitem expiration due date 2013-02-15 underlying security shares 15000.0000 underlying security title Common Stock

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on may 31, 2012.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-06-29 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-015065.txt Sec File: edgar/data/1346974/0001225208-12-015065-index.htm

2012-06-29 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 14800 shares at $103.0000 remaining shares owned 46366

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on may 31, 2012.
f3 this transaction was executed in multiple trades at prices ranging from $102.40 to $103.38. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-06-29 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-015065.txt Sec File: edgar/data/1346974/0001225208-12-015065-index.htm

2012-06-29 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 200 shares at $103.4700 remaining shares owned 61166

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on may 31, 2012.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-06-29 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-015065.txt Sec File: edgar/data/1346974/0001225208-12-015065-index.htm

2012-06-29 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 15000 shares at $21.5000 remaining shares owned 61366

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on may 31, 2012.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-05-16 by Abate Thomas M SEC CIK 1346974 Form 4/a

Accession 0001225208-12-012589.txt Sec File: edgar/data/1346974/0001225208-12-012589-index.htm

2012-05-08 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 2850 shares at $85.4900 remaining shares owned 43016

Common Stock Edwards Lifesciences Corp Ew Transaction code: F Payment of exercise price or tax liability by delivering or withholding securities

f1 this amendment is being filed to correct an inadvertent clerical error in the number of shares of common stock withheld to cover taxes incident to vesting of previously granted restricted stock units.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-05-11 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-012014.txt Sec File: edgar/data/1346974/0001225208-12-012014-index.htm

2012-05-09 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 3350.0000 shares at $0.0000 remaining shares owned 3350

Performance Rights Edwards Lifesciences Corp Ew item expiration due date 2015-03-31 underlying security shares 3350.0000 underlying security title Common Stock

f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.
f4 reflects the target number of shares (the target award) covered by unvested restricted stock units granted on may 9, 2012. the number of shares issuable at vesting will depend upon achievement of the performance goals and will range from zero percent (0%) of the target award to one hundred seventy five percent (175%) of the target award.


Filed on 2012-05-11 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-012014.txt Sec File: edgar/data/1346974/0001225208-12-012014-index.htm

2012-05-09 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 34700.0000 shares at $0.0000 remaining shares owned 34700

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2012-06-09 exercise price 85.4500 has valueitem expiration due date 2019-05-08 underlying security shares 34700.0000 underlying security title Common Stock

f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.
f3 this option was granted on may 9, 2012 under the edwards lifesciences corporation long-term stock incentive compensation program and becomes exercisable commencing one month after the grant date in twenty-four equal monthly installments.


Filed on 2012-05-11 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-012014.txt Sec File: edgar/data/1346974/0001225208-12-012014-index.htm

2012-05-09 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 3350 shares at $0.0000 remaining shares owned 46236

Common Stock Edwards Lifesciences Corp Ew Transaction code: A Grant, award, or other acquisition

f1 reflects unvested restricted stock units granted on may 9, 2012.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-05-08 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-011552.txt Sec File: edgar/data/1346974/0001225208-12-011552-index.htm

2012-05-08 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 2980 shares at $85.4900 remaining shares owned 42886

Common Stock Edwards Lifesciences Corp Ew Transaction code: F Payment of exercise price or tax liability by delivering or withholding securities

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-05-08 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-011552.txt Sec File: edgar/data/1346974/0001225208-12-011552-index.htm

2012-05-07 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 2036 shares at $84.9900 remaining shares owned 45866

Common Stock Edwards Lifesciences Corp Ew Transaction code: F Payment of exercise price or tax liability by delivering or withholding securities

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-05-03 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-011152.txt Sec File: edgar/data/1346974/0001225208-12-011152-index.htm

2012-05-01 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 7400 shares at $84.4500 remaining shares owned 47902

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f5 this transaction was executed in multiple trades at prices ranging from $84.41 to $85.03. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-05-03 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-011152.txt Sec File: edgar/data/1346974/0001225208-12-011152-index.htm

2012-05-01 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 10000.0000 shares at $0.0000 remaining shares owned 16200

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2006-05-12 exercise price 22.9500 has valueitem expiration due date 2012-05-11 underlying security shares 10000.0000 underlying security title Common Stock

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-05-03 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-011152.txt Sec File: edgar/data/1346974/0001225208-12-011152-index.htm

2012-05-01 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 1600 shares at $83.9400 remaining shares owned 55302

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f4 this transaction was executed in multiple trades at prices ranging from $83.36 to $84.17. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-05-03 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-011152.txt Sec File: edgar/data/1346974/0001225208-12-011152-index.htm

2012-05-01 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 1000 shares at $82.7200 remaining shares owned 56902

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f3 this transaction was executed in multiple trades at prices ranging from $82.25 to $83.12. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-05-03 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-011152.txt Sec File: edgar/data/1346974/0001225208-12-011152-index.htm

2012-05-01 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 10000 shares at $22.9500 remaining shares owned 57902

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-04-27 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-010387.txt Sec File: edgar/data/1346974/0001225208-12-010387-index.htm

2012-04-26 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 10000.0000 shares at $0.0000 remaining shares owned 0

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2003-05-08 exercise price 13.0050 has valueitem expiration due date 2012-05-07 underlying security shares 10000.0000 underlying security title Common Stock

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-04-27 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-010387.txt Sec File: edgar/data/1346974/0001225208-12-010387-index.htm

2012-04-26 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 9459 shares at $81.4300 remaining shares owned 47902

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f4 this transaction was executed in multiple trades at prices ranging from $80.95 to $81.93. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-04-27 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-010387.txt Sec File: edgar/data/1346974/0001225208-12-010387-index.htm

2012-04-26 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 541 shares at $82.1000 remaining shares owned 57361

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f3 this transaction was executed in multiple trades at prices ranging from $82.04 to $82.17. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-04-27 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-010387.txt Sec File: edgar/data/1346974/0001225208-12-010387-index.htm

2012-04-26 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 10000 shares at $13.0050 remaining shares owned 57902

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-04-09 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-009596.txt Sec File: edgar/data/1346974/0001225208-12-009596-index.htm

2012-04-06 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 153 shares at $71.9900 remaining shares owned 47902

Common Stock Edwards Lifesciences Corp Ew Transaction code: F Payment of exercise price or tax liability by delivering or withholding securities

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-04-09 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-009596.txt Sec File: edgar/data/1346974/0001225208-12-009596-index.htm

2012-04-04 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 177 shares at $73.1600 remaining shares owned 48055

Common Stock Edwards Lifesciences Corp Ew Transaction code: F Payment of exercise price or tax liability by delivering or withholding securities

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-04-04 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-009363.txt Sec File: edgar/data/1346974/0001225208-12-009363-index.htm

2012-04-03 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 362 shares at $0.0000 remaining shares owned 48232

Common Stock Edwards Lifesciences Corp Ew Transaction code: A Grant, award, or other acquisition

f1 reflects unvested restricted stock units granted on april 3, 2012.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person. this amount includes quarterly acquisition of shares under the edwards lifesciences corporation employee stock purchase plan as reflected on the most recent report of the plan administrator.


Filed on 2012-03-30 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-008522.txt Sec File: edgar/data/1346974/0001225208-12-008522-index.htm

2012-03-29 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 10000 shares at $22.9500 remaining shares owned 57625

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-03-30 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-008522.txt Sec File: edgar/data/1346974/0001225208-12-008522-index.htm

2012-03-29 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 10000.0000 shares at $0.0000 remaining shares owned 26200

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2006-05-12 exercise price 22.9500 has valueitem expiration due date 2012-05-11 underlying security shares 10000.0000 underlying security title Common Stock

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-03-30 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-008522.txt Sec File: edgar/data/1346974/0001225208-12-008522-index.htm

2012-03-29 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 10000 shares at $72.8000 remaining shares owned 47625

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f3 this transaction was executed in multiple trades at prices ranging from $72.61 to $73.35. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-03-15 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-007699.txt Sec File: edgar/data/1346974/0001225208-12-007699-index.htm

2012-03-15 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 10000.0000 shares at $0.0000 remaining shares owned 10000

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2003-05-08 exercise price 13.0050 has valueitem expiration due date 2012-05-07 underlying security shares 10000.0000 underlying security title Common Stock

f2 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-03-15 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-007699.txt Sec File: edgar/data/1346974/0001225208-12-007699-index.htm

2012-03-15 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 5100 shares at $69.5700 remaining shares owned 47625

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f2 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f4 this transaction was executed in multiple trades at prices ranging from $68.95 to $69.94. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-03-15 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-007699.txt Sec File: edgar/data/1346974/0001225208-12-007699-index.htm

2012-03-15 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 4900 shares at $70.1300 remaining shares owned 52725

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f2 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f3 this transaction was executed in multiple trades at prices ranging from $69.95 to $70.30. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-03-15 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-007699.txt Sec File: edgar/data/1346974/0001225208-12-007699-index.htm

2012-03-15 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 10000 shares at $13.0050 remaining shares owned 57625

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f2 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-03-15 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-007699.txt Sec File: edgar/data/1346974/0001225208-12-007699-index.htm

2012-02-29 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 300 shares at $0.0000 remaining shares owned 47625

Common Stock Edwards Lifesciences Corp Ew Transaction code: G Bona fide gift form of any clauses

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-02-23 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-005288.txt Sec File: edgar/data/1346974/0001225208-12-005288-index.htm

2012-02-23 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 10000.0000 shares at $0.0000 remaining shares owned 36200

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2006-05-12 exercise price 22.9500 has valueitem expiration due date 2012-05-11 underlying security shares 10000.0000 underlying security title Common Stock

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-02-23 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-005288.txt Sec File: edgar/data/1346974/0001225208-12-005288-index.htm

2012-02-23 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 10000 shares at $74.1200 remaining shares owned 47925

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f3 this transaction was executed in multiple trades at prices ranging from $73.73 to $74.63. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-02-23 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-005288.txt Sec File: edgar/data/1346974/0001225208-12-005288-index.htm

2012-02-23 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 10000 shares at $22.9500 remaining shares owned 57925

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-02-10 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-003757.txt Sec File: edgar/data/1346974/0001225208-12-003757-index.htm

2012-02-09 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 10000.0000 shares at $0.0000 remaining shares owned 20000

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2003-05-08 exercise price 13.0050 has valueitem expiration due date 2012-05-07 underlying security shares 10000.0000 underlying security title Common Stock

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-02-10 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-003757.txt Sec File: edgar/data/1346974/0001225208-12-003757-index.htm

2012-02-09 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 10000 shares at $73.4200 remaining shares owned 47925

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f3 this transaction was executed in multiple trades at prices ranging from $73.25 to $73.94. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-02-10 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-003757.txt Sec File: edgar/data/1346974/0001225208-12-003757-index.htm

2012-02-09 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 10000 shares at $13.0050 remaining shares owned 57925

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-01-12 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-001302.txt Sec File: edgar/data/1346974/0001225208-12-001302-index.htm

2012-01-12 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 10000.0000 shares at $0.0000 remaining shares owned 30000

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2003-05-08 exercise price 13.0050 has valueitem expiration due date 2012-05-07 underlying security shares 10000.0000 underlying security title Common Stock

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-01-12 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-001302.txt Sec File: edgar/data/1346974/0001225208-12-001302-index.htm

2012-01-12 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 10000 shares at $73.9100 remaining shares owned 47925

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f3 this transaction was executed in multiple trades at prices ranging from $73.41 to $74.36. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-01-12 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-001302.txt Sec File: edgar/data/1346974/0001225208-12-001302-index.htm

2012-01-12 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 10000 shares at $13.0050 remaining shares owned 57925

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-01-03 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-000156.txt Sec File: edgar/data/1346974/0001225208-12-000156-index.htm

2011-12-29 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 10000.0000 shares at $0.0000 remaining shares owned 40000

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2003-05-08 exercise price 13.0050 has valueitem expiration due date 2012-05-07 underlying security shares 10000.0000 underlying security title Common Stock

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-01-03 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-000156.txt Sec File: edgar/data/1346974/0001225208-12-000156-index.htm

2011-12-29 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 1332.0000 shares at $0.0000 remaining shares owned 0

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2004-04-04 exercise price 13.4700 has valueitem expiration due date 2012-04-03 underlying security shares 1332.0000 underlying security title Common Stock

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-01-03 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-000156.txt Sec File: edgar/data/1346974/0001225208-12-000156-index.htm

2011-12-29 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 9532 shares at $71.2100 remaining shares owned 47925

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f4 this transaction was executed in multiple trades at prices ranging from $70.98 to $71.41. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-01-03 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-000156.txt Sec File: edgar/data/1346974/0001225208-12-000156-index.htm

2011-12-29 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 1800 shares at $70.5200 remaining shares owned 57457

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f3 this transaction was executed in multiple trades at prices ranging from $69.98 to $70.89. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-01-03 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-000156.txt Sec File: edgar/data/1346974/0001225208-12-000156-index.htm

2011-12-29 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 1332 shares at $13.4700 remaining shares owned 59257

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2012-01-03 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-12-000156.txt Sec File: edgar/data/1346974/0001225208-12-000156-index.htm

2011-12-29 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 10000 shares at $13.0050 remaining shares owned 57925

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 29, 2011.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2011-09-01 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-11-021222.txt Sec File: edgar/data/1346974/0001225208-11-021222-index.htm

2011-08-31 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 7929.0000 shares at $0.0000 remaining shares owned 14105

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2005-11-04 exercise price 17.3550 has valueitem expiration due date 2011-11-03 underlying security shares 7929.0000 underlying security title Common Stock

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2011-09-01 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-11-021222.txt Sec File: edgar/data/1346974/0001225208-11-021222-index.htm

2011-08-30 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 7966.0000 shares at $0.0000 remaining shares owned 22034

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2005-11-04 exercise price 17.3550 has valueitem expiration due date 2011-11-03 underlying security shares 7966.0000 underlying security title Common Stock

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2011-09-01 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-11-021222.txt Sec File: edgar/data/1346974/0001225208-11-021222-index.htm

2011-08-31 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 7929 shares at $75.1600 remaining shares owned 47925

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f3 this transaction was executed in multiple trades at prices ranging from $74.69 to $75.57. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2011-09-01 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-11-021222.txt Sec File: edgar/data/1346974/0001225208-11-021222-index.htm

2011-08-31 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 7929 shares at $17.3550 remaining shares owned 55854

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2011-09-01 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-11-021222.txt Sec File: edgar/data/1346974/0001225208-11-021222-index.htm

2011-08-30 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 7966 shares at $73.7200 remaining shares owned 47925

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f2 this transaction was executed in multiple trades at prices ranging from $73.55 to $73.96. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2011-09-01 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-11-021222.txt Sec File: edgar/data/1346974/0001225208-11-021222-index.htm

2011-08-30 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 7966 shares at $17.3550 remaining shares owned 55891

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2011-05-16 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-11-014531.txt Sec File: edgar/data/1346974/0001225208-11-014531-index.htm

2011-05-12 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 40400.0000 shares at $0.0000 remaining shares owned 40400

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2011-06-12 exercise price 89.2300 has valueitem expiration due date 2018-05-11 underlying security shares 40400.0000 underlying security title Common Stock

f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.
f3 this option was granted on may 12, 2011 under the edwards lifesciences corporation long-term stock incentive compensation program and becomes exercisable commencing one month after the grant date in twenty-four equal monthly installments.


Filed on 2011-05-16 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-11-014531.txt Sec File: edgar/data/1346974/0001225208-11-014531-index.htm

2011-05-12 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 3575 shares at $0.0000 remaining shares owned 47925

Common Stock Edwards Lifesciences Corp Ew Transaction code: A Grant, award, or other acquisition

f1 reflects unvested restricted stock units granted on may 12, 2011.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2011-05-10 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-11-013882.txt Sec File: edgar/data/1346974/0001225208-11-013882-index.htm

2011-05-10 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 2668 shares at $88.0700 remaining shares owned 44350

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2011-05-10 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-11-013882.txt Sec File: edgar/data/1346974/0001225208-11-013882-index.htm

2011-05-09 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 2185 shares at $88.2000 remaining shares owned 47018

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2011-04-05 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-11-011342.txt Sec File: edgar/data/1346974/0001225208-11-011342-index.htm

2011-04-04 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 136 shares at $86.0700 remaining shares owned 49203

Common Stock Edwards Lifesciences Corp Ew Transaction code: F Payment of exercise price or tax liability by delivering or withholding securities

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2011-04-05 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-11-011342.txt Sec File: edgar/data/1346974/0001225208-11-011342-index.htm

2011-04-04 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp bought 307 shares at $0.0000 remaining shares owned 49339

Common Stock Edwards Lifesciences Corp Ew Transaction code: A Grant, award, or other acquisition

f2 reflects unvested restricted stock units granted on april 4, 2011.
f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2011-04-05 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-11-011342.txt Sec File: edgar/data/1346974/0001225208-11-011342-index.htm

2011-04-03 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo)

Invested in Edwards Lifesciences Corp sold 122 shares at $86.0700 remaining shares owned 49032

Common Stock Edwards Lifesciences Corp Ew Transaction code: F Payment of exercise price or tax liability by delivering or withholding securities

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2010-11-23 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-10-025548.txt Sec File: edgar/data/1346974/0001225208-10-025548-index.htm

2010-11-22 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp sold 1840.0000 shares at $0.0000 remaining shares owned 0

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2005-04-03 exercise price 16.0750 has valueitem expiration due date 2011-04-02 underlying security shares 1840.0000 underlying security title Common Stock

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2010-11-23 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-10-025548.txt Sec File: edgar/data/1346974/0001225208-10-025548-index.htm

2010-11-22 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp sold 1782.0000 shares at $0.0000 remaining shares owned 0

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2003-04-03 exercise price 9.2000 has valueitem expiration due date 2011-04-03 underlying security shares 1782.0000 underlying security title Common Stock

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2010-11-23 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-10-025548.txt Sec File: edgar/data/1346974/0001225208-10-025548-index.htm

2010-11-22 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp sold 24000.0000 shares at $0.0000 remaining shares owned 0

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2003-02-08 exercise price 9.2500 has valueitem expiration due date 2011-02-08 underlying security shares 24000.0000 underlying security title Common Stock

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2010-11-23 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-10-025548.txt Sec File: edgar/data/1346974/0001225208-10-025548-index.htm

2010-11-23 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp sold 6000 shares at $65.6800 remaining shares owned 49154

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f3 this transaction was executed in multiple trades at prices ranging from $65.67 to $65.77. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2010-11-23 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-10-025548.txt Sec File: edgar/data/1346974/0001225208-10-025548-index.htm

2010-11-22 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp sold 33622 shares at $66.8500 remaining shares owned 55154

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f2 this transaction was executed in multiple trades at prices ranging from $66.77 to $66.99. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2010-11-23 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-10-025548.txt Sec File: edgar/data/1346974/0001225208-10-025548-index.htm

2010-11-22 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 1782 shares at $9.2000 remaining shares owned 88776

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2010-11-23 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-10-025548.txt Sec File: edgar/data/1346974/0001225208-10-025548-index.htm

2010-11-22 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 1840 shares at $16.0750 remaining shares owned 86994

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2010-11-23 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-10-025548.txt Sec File: edgar/data/1346974/0001225208-10-025548-index.htm

2010-11-22 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 24000 shares at $9.2500 remaining shares owned 85154

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2010-05-17 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-10-013179.txt Sec File: edgar/data/1346974/0001225208-10-013179-index.htm

2010-05-13 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 30900 shares at $0 remaining shares owned 30900

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2010-06-13 exercise price 101.92 has valueitem expiration due date 2017-05-12 underlying security shares 30900 underlying security title Common Stock

f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.
f3 this option was granted on may 13, 2010 under the edwards lifesciences corporation long-term stock incentive compensation program and becomes exercisable commencing one month after the grant date in twenty-four equal monthly installments.


Filed on 2010-05-17 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-10-013179.txt Sec File: edgar/data/1346974/0001225208-10-013179-index.htm

2010-05-13 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 2700 shares at $0 remaining shares owned 30577

Common Stock Edwards Lifesciences Corp Ew Transaction code: A Grant, award, or other acquisition

f1 reflects unvested restricted stock units granted on may 13, 2010.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2010-04-06 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-10-010066.txt Sec File: edgar/data/1346974/0001225208-10-010066-index.htm

2010-04-05 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 293 shares at $0 remaining shares owned 27877

Common Stock Edwards Lifesciences Corp Ew Transaction code: A Grant, award, or other acquisition

f1 reflects unvested restricted stock units granted on april 5, 2010.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2010-02-25 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-10-005839.txt Sec File: edgar/data/1346974/0001225208-10-005839-index.htm

2010-02-23 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp sold 50000 shares at $0 remaining shares owned 0

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2004-05-14 exercise price 30.43 has valueitem expiration due date 2010-05-13 underlying security shares 50000 underlying security title Common Stock

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2010-02-25 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-10-005839.txt Sec File: edgar/data/1346974/0001225208-10-005839-index.htm

2010-02-23 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp sold 50000 shares at $90.24 remaining shares owned 27584

Common Stock Edwards Lifesciences Corp Ew Transaction code: S Open market or private sale of securities

f2 this transaction was executed in multiple trades at prices ranging from $90.00 to $91.00. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2010-02-25 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-10-005839.txt Sec File: edgar/data/1346974/0001225208-10-005839-index.htm

2010-02-23 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 50000 shares at $30.43 remaining shares owned 77584

Common Stock Edwards Lifesciences Corp Ew Transaction code: M Exercise or conversion of derivative security

f1 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2009-05-11 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-09-012177.txt Sec File: edgar/data/1346974/0001225208-09-012177-index.htm

2009-05-07 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 45000 shares at $0 remaining shares owned 45000

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2009-06-07 exercise price 62.94 has valueitem expiration due date 2016-05-06 underlying security shares 45000 underlying security title Common Stock

f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.
f3 this option was granted on may 7, 2009 under the edwards lifesciences corporation long-term stock incentive compensation program and becomes exercisable commencing one month after the grant date in twenty-four equal monthly installments.


Filed on 2009-05-11 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-09-012177.txt Sec File: edgar/data/1346974/0001225208-09-012177-index.htm

2009-05-07 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 4500 shares at $0 remaining shares owned 27584

Common Stock Edwards Lifesciences Corp Ew Transaction code: A Grant, award, or other acquisition

f1 reflects unvested restricted stock units granted on may 7, 2009.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2009-04-08 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-09-010116.txt Sec File: edgar/data/1346974/0001225208-09-010116-index.htm

2009-04-06 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 338 shares at $0 remaining shares owned 23084

Common Stock Edwards Lifesciences Corp Ew Transaction code: A Grant, award, or other acquisition

f1 reflects unvested restricted stock units granted on april 6, 2009.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2008-05-12 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-08-008361.txt Sec File: edgar/data/1346974/0001225208-08-008361-index.htm

2008-05-08 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 50400 shares at $0 remaining shares owned 50400

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2008-06-08 exercise price 55.54 has valueitem expiration due date 2015-05-07 underlying security shares 50400 underlying security title Common Stock

f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.
f3 this option was granted on may 8, 2008 under the edwards lifesciences corporation long-term stock incentive compensation program and becomes exercisable commencing one month after the grant date in thirty-six equal monthly installments.


Filed on 2008-05-12 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-08-008361.txt Sec File: edgar/data/1346974/0001225208-08-008361-index.htm

2008-05-08 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 6200 shares at $0 remaining shares owned 22746

Common Stock Edwards Lifesciences Corp Ew Transaction code: A Grant, award, or other acquisition

f1 reflects unvested restricted stock units granted on may 8, 2008.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2008-04-07 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-08-006313.txt Sec File: edgar/data/1346974/0001225208-08-006313-index.htm

2008-04-04 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 385 shares at $0 remaining shares owned 16546

Common Stock Edwards Lifesciences Corp Ew Transaction code: A Grant, award, or other acquisition

f1 reflects unvested restricted stock units granted on april 4, 2008.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2007-05-14 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-07-004779.txt Sec File: edgar/data/1346974/0001225208-07-004779-index.htm

2007-05-10 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 47000 shares at $0 remaining shares owned 47000

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2008-05-10 exercise price 48.84 has valueitem expiration due date 2014-05-14 underlying security shares 47000 underlying security title Common Stock

f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.
f3 this option was granted on may 10, 2007 under the edwards lifesciences corporation long-term stock incentive compensation program and becomes exercisable commencing one year after the grant date in four equal annual installments.


Filed on 2007-05-14 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-07-004779.txt Sec File: edgar/data/1346974/0001225208-07-004779-index.htm

2007-05-10 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 6000 shares at $0 remaining shares owned 16161

Common Stock Edwards Lifesciences Corp Ew Transaction code: A Grant, award, or other acquisition

f1 reflects unvested restricted stock units granted on may 10, 2007.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2007-04-06 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001225208-07-003698.txt Sec File: edgar/data/1346974/0001225208-07-003698-index.htm

2007-04-04 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 337 shares at $0 remaining shares owned 10161

Common Stock Edwards Lifesciences Corp Ew Transaction code: A Grant, award, or other acquisition

f1 reflects unvested restricted stock units granted on april 4, 2007.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2006-05-15 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001179110-06-010888.txt Sec File: edgar/data/1346974/0001179110-06-010888-index.htm

2006-05-11 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 46000 shares at $0 remaining shares owned 46000

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2009-05-11 exercise price 43.91 has valueitem expiration due date 2013-05-10 underlying security shares 46000 underlying security title Common Stock

f3 this option was granted on may 11, 2006 under the edwards lifesciences corporation long-term stock incentive compensation program and becomes exercisable as to 50% after three years from grant date and 100% after four years from grant date.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2006-05-15 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001179110-06-010888.txt Sec File: edgar/data/1346974/0001179110-06-010888-index.htm

2006-05-11 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 137 shares at $0 remaining shares owned 9824

Common Stock Edwards Lifesciences Corp Ew Transaction code: A Grant, award, or other acquisition

f1 reflects unvested restricted stock units granted on may 11, 2006.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2006-05-15 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001179110-06-010888.txt Sec File: edgar/data/1346974/0001179110-06-010888-index.htm

2006-05-11 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 6000 shares at $0 remaining shares owned 9687

Common Stock Edwards Lifesciences Corp Ew Transaction code: A Grant, award, or other acquisition

f1 reflects unvested restricted stock units granted on may 11, 2006.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2006-04-05 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001179110-06-008064.txt Sec File: edgar/data/1346974/0001179110-06-008064-index.htm

2006-04-04 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 215 shares at $0 remaining shares owned 3687

Common Stock Edwards Lifesciences Corp Ew Transaction code: A Grant, award, or other acquisition

f1 reflect unvested restricted stock units granted on april 4, 2006.
f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.


Filed on 2006-02-17 by Abate Thomas M SEC CIK 1346974 Form 4

Accession 0001179110-06-004249.txt Sec File: edgar/data/1346974/0001179110-06-004249-index.htm

2006-02-16 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp bought 25000 shares at $0 remaining shares owned 25000

Employee Stock Option Right To Acquire Edwards Lifesciences Corp Ew exercise date 2007-02-15 exercise price 43.00 has valueitem expiration due date 2013-02-15 underlying security shares 25000 underlying security title Common Stock

f2 this form 4 reflects changes in beneficial ownership only; it does not identify other securities of the issuer beneficially owned by the reporting person.
f1 this option was granted on february 16, 2006 under the edwards lifesciences corporation long-term stock incentive compensation program and becomes exercisable commencing one year after the grant date in four equal annual installments.


Filed on 2006-01-10 by Abate Thomas M SEC CIK 1346974 Form 3

Accession 0001179110-06-001162.txt Sec File: edgar/data/1346974/0001179110-06-001162-index.htm

2006-01-01 Abate Thomas M (CIK 1346974) through Direct (Cvp Cfo And Treasurer)

Invested in Edwards Lifesciences Corp remaining shares owned 3472

Common Stock Edwards Lifesciences Corp Ew